Drug wholesaler McKesson Corp. has agreed to pay $1.4 million to the MaineCare program as part of a national health care fraud settlement. In announcing the settlement on Friday, Maine Attorney General William Schneider said McKesson violated the Federal False Claims Act and various state statutes by reporting inflated pricing information for a large number of prescription drugs, causing the state's Medicaid program to overpay for those drugs.
"The state paid artificially high prices due to the manipulation of the drug reimbursement system by this corporation," said Schneider in a press release. "Through this settlement, MaineCare will receive restitution for those excessive payments."
The suit was filed in U.S. District Court in New Jersey. Maine was represented by a national settlement team comprised of members from the states of California and New York working through the National Association of Medicaid Fraud Control Units.
In April, the federal government settled the federal portion of this lawsuit for more than $187 million.